Biogen Idec reports positive top-line results from Phase 2 anti-LINGO-1 trial in people with acute optic neuritis Biogen Idec, 8 Jan 2015 Accessed on 13 Jan 2015 from http://www.biogenidec.com/press_release_details.aspx?ID=14712&Action=1&NewsId=2452&M=NewsV2&PID=61997. CommentRecommendBookmarkWatch